Kali’s services are remote, accessible, affordable and personal for every patient
One platform, multiple conditions.
Chronic Conditions
24/7 monitoring
Pre-prescription assessment
Post-prescription assessment & progress
Personalized digital intervention & engagement programs
Surgery
24/7 monitoring
Pre-surgery assessment & education
Post-surgery assessment
Personalized digital intervention
Our solutions
Patient Engagement Assessment
AI-based predictive tool to determine behavioral factors related to medication adherence. Clinically proven to accurately identify specific barriers to adherence and develop potential interventions to improve adherence.
Kali’s Connected Therapeutics
Connected therapeutics for continuous medication event monitoring. Proven technology to automatically collect and record objective medication-use data. Making available ever-greater amounts of data from which advanced analytics can mine insights and provide personalized interventions.
Digital Health Intervention
We use patient-specific health behavior factors and objective medication adherence data to identify risk patients, select the adequate communication channel and personalize the interventions to improve patient adherence and experience. The interventions include SMS messaging, voice chat-bot, mobile app, direct phone call.
Kali works with
Eye Care Providers
Clinical practice efficiency: Kali improves staff resources through patient triage. Urgent and emergent patients scheduled faster while non-emergency patients and patients who are doing well are monitored at home.
Facilitation of telemedicine: early detection and tele-communication with at-risk non-adherent patients.
Incremental new revenue: leverages new telemedicine reimbursement code. Utilize QHP for telemedicine follow-up.
Health Systems
Better care at lower cost: through Kali patient engagement and adherence program.
At-home patient care: help patient to better manage their chronic conditions at home.
Reduce operational cost: through automation, patient triage, digital intervention, and digital communication channels such as SMS, chat-bot, and email.
Pharma: Connected Therapeutics
Assessment programs: Kali provides the only clinically validated assessment tool to predict patient factors associated with adherence.
Post-prescription programs: adherence monitoring and support programs for existing patient population.
Co-packaging: Kali sensor and digital services will be packaged and prescribed alongside an existing ophthalmic medication.
Combined digital therapeutics: Kali digital solution will be combined with the medication during clinical trials and will be commercialized as combined therapy through FDA clearance.
Pharma: Clinical Trials
Data accuracy: by distinguishing non-responders from non-adherent participants, Kali provides accurate data about efficacy and toxicity patterns.
Timeliness: Kali collects and analyzes thousands of medication-use data within minutes rather than months as opposed to when done by manual processes.
Patient engagement: enables interventions to address adherence issues if appropriate in study design.
Worldwide services: Kali’s solution has been used in Phase 2 & 3 and marketing studies. It has been deployed across 200 sites, 150 investigators, and 98 cities located in 20+ countries.